Global disease experts say little is known about China's experience with long-term COVID effects thought to have afflicted millions with debilitating fatigue, brain fog and other symptoms
Public Health England: AstraZeneca COVID shot 94% protective against death in over 65s
Two doses of the Oxford/AstraZeneca COVID-19 vaccine gives an estimated 94 percent protection against death from the disease in people over 65, Public Health England said on Thursday in a weekly surveillance report of real-world data.
Published : 1 July 2021, 03:28 PM
Updated : 1 July 2021, 03:28 PM
PHE said the majority of the data was derived from a period when the Alpha variant, first detected in England, was still dominant and did not provide a specific estimate of protection from death that the vaccine offered against the now more widespread Delta variant, first detected in India.
PHE also said that for the under 40s, early estimates suggested a single dose of Pfizer's vaccine is 61 percent effective against symptomatic disease and a single dose of the Moderna vaccine is 72 percent effective.
"This data gives us even more confidence that the vaccines offer high levels of protection against COVID-19 across all age groups," said Jamie Lopez Bernal, consultant epidemiologist at PHE.
RELATED STORIES
The demonstrations helped to end COVID restrictions but failed to achieve lasting political change, six participants based in China and overseas say
The agency seeks details on an increase in respiratory illnesses and reported clusters of pneumonia in children, which its China office called a ‘routine’ check
The inquiry is examining the government's response to the coronavirus pandemic that shut large sections of the economy and killed more than 220,000 people in Britain
